008490.KS
Suheung Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 21,350.00
−0.23%Year over year
Reported trailing growth
- Revenue
- +11.6%
- EBITDA
- -36.3%
- EBIT
- +46.6%
- EPS
- -4.9%
- Free cash flow
- +44.8%
- Operating cash flow
- +38.1%
Forward estimates
Based on analyst estimates
- Revenue
- -24.1%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- -2.6%
- EBIT
- -6.5%
- Net income
- +8.6%
- EPS
- +8.6%
- Free cash flow
- +106.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026